IL6 and systemic sclerosis: Recently, B-cell-activating factor (BAFF), an essential component of B-cell homeostasis and a potent B-cell survival factor associated with autoimmune disease, was shown to be increased in SSc patients compared to healthy controls [36], and the ability of B cells to produce IL-6 is significantly increased by BAFF stimulation [37].